France
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 51.62 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
2 |
USD 49.39 M
|
Dec. 31, 2023 | USD 28.61 | 0.98% |
|
France |
|
3 |
USD 23.94 M
|
Dec. 31, 2023 | USD 7.91 | 1.05% |
|
France |
|
4 |
USD 21.77 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
5 |
USD 12.49 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
6 |
USD 5.71 M
|
Dec. 31, 2023 | USD 1.18 | 2.98% |
|
France |
|
7 |
USD 3.37 M
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
8 |
USD 2.67 M
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
9 |
USD 1.52 M
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
10 |
USD -30.85 K
|
Dec. 31, 2023 | USD 7.60 | -5.89% |
|
France |
|
11 |
USD -654.52 K
|
Dec. 31, 2023 | USD 3.60 | 1.72% |
|
France |
|
12 |
USD -1.01 M
|
Dec. 31, 2023 | USD 2.44 | 6.09% |
|
France |
|
13 |
USD -5.05 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
14 |
USD -25.94 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
15 |
USD -67.57 M
|
Dec. 31, 2023 | USD 28.77 | 0.25% |
|
France |
|
16 |
USD -134.99 M
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
17 |
USD -431.71 M
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
The Medical Instruments company in France with the highest Net Cash Used Provided By Financing Activities is Nanobiotix S.A. (Paris Stock Exchange: NANO.PA) at USD 51.62 M.
The Medical Instruments company in France with the lowest Net Cash Used Provided By Financing Activities is Ramsay Générale de Santé SA (Paris Stock Exchange: GDS.PA) at USD -431.71 M.
The top 10 Medical Instruments companies in France by Net Cash Used Provided By Financing Activities are Nanobiotix S.A., Guerbet SA, Lumibird SA, Median Technologies SA, Affluent Medical SA, Biosynex SA, Predilife S.A., Amplitude Surgical SA, Ikonisys S.A. and i2S SA.
The bottom 10 Medical Instruments companies in France by Net Cash Used Provided By Financing Activities are Ramsay Générale de Santé SA, bioMérieux S.A., Lisi S.A., Eurobio Scientific SA, Novacyt S.A., EDAP TMS S.A., MEMSCAP, S.A., i2S SA, Ikonisys S.A. and Amplitude Surgical SA.